For example, overexpression of miR-206 was used to treat breast cancer cells to inhibit the downstream genes of transforming growth factor (TGF)-β, such as NRP1 and SMAD2, to reduce the migration and invasion of breast cancer cells [51]. This evidence concerns the gene NRP1 and breast carcinoma.